725 related articles for article (PubMed ID: 24780473)
21. Renal Drug Transporters and Drug Interactions.
Ivanyuk A; Livio F; Biollaz J; Buclin T
Clin Pharmacokinet; 2017 Aug; 56(8):825-892. PubMed ID: 28210973
[TBL] [Abstract][Full Text] [Related]
22. Human renal organic anion transporters: characteristics and contributions to drug and drug metabolite excretion.
Robertson EE; Rankin GO
Pharmacol Ther; 2006 Mar; 109(3):399-412. PubMed ID: 16169085
[TBL] [Abstract][Full Text] [Related]
23. Uremic toxins: a new focus on an old subject.
Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
[TBL] [Abstract][Full Text] [Related]
24. Role of kidney-specific organic anion transporters in the urinary excretion of methotrexate.
Takeuchi A; Masuda S; Saito H; Doi T; Inui K
Kidney Int; 2001 Sep; 60(3):1058-68. PubMed ID: 11532100
[TBL] [Abstract][Full Text] [Related]
25. Renal tubular secretion of tanshinol: molecular mechanisms, impact on its systemic exposure, and propensity for dose-related nephrotoxicity and for renal herb-drug interactions.
Jia W; Du F; Liu X; Jiang R; Xu F; Yang J; Li L; Wang F; Olaleye OE; Dong J; Li C
Drug Metab Dispos; 2015 May; 43(5):669-78. PubMed ID: 25710938
[TBL] [Abstract][Full Text] [Related]
26. Uremic Toxins in Organ Crosstalk.
Lowenstein J; Nigam SK
Front Med (Lausanne); 2021; 8():592602. PubMed ID: 33937275
[TBL] [Abstract][Full Text] [Related]
27. Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats.
Naud J; Michaud J; Beauchemin S; Hébert MJ; Roger M; Lefrancois S; Leblond FA; Pichette V
Drug Metab Dispos; 2011 Aug; 39(8):1363-9. PubMed ID: 21525170
[TBL] [Abstract][Full Text] [Related]
28. Uremic Toxin Clearance and Cardiovascular Toxicities.
Mair RD; Sirich TL; Meyer TW
Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29865226
[TBL] [Abstract][Full Text] [Related]
29. The rebirth of interest in renal tubular function.
Lowenstein J; Grantham JJ
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1351-5. PubMed ID: 26936872
[TBL] [Abstract][Full Text] [Related]
30. Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity.
Enomoto A; Takeda M; Tojo A; Sekine T; Cha SH; Khamdang S; Takayama F; Aoyama I; Nakamura S; Endou H; Niwa T
J Am Soc Nephrol; 2002 Jul; 13(7):1711-20. PubMed ID: 12089366
[TBL] [Abstract][Full Text] [Related]
31. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
Perri D; Ito S; Rowsell V; Shear NH
Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
[TBL] [Abstract][Full Text] [Related]
32. Effects of renal failure on drug transport and metabolism.
Sun H; Frassetto L; Benet LZ
Pharmacol Ther; 2006 Jan; 109(1-2):1-11. PubMed ID: 16085315
[TBL] [Abstract][Full Text] [Related]
33. Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients.
Mutsaers HA; Engelke UF; Wilmer MJ; Wetzels JF; Wevers RA; van den Heuvel LP; Hoenderop JG; Masereeuw R
PLoS One; 2013; 8(8):e71199. PubMed ID: 23936492
[TBL] [Abstract][Full Text] [Related]
34. Transport of the dipeptidyl peptidase-4 inhibitor sitagliptin by human organic anion transporter 3, organic anion transporting polypeptide 4C1, and multidrug resistance P-glycoprotein.
Chu XY; Bleasby K; Yabut J; Cai X; Chan GH; Hafey MJ; Xu S; Bergman AJ; Braun MP; Dean DC; Evers R
J Pharmacol Exp Ther; 2007 May; 321(2):673-83. PubMed ID: 17314201
[TBL] [Abstract][Full Text] [Related]
35. Future Avenues to Decrease Uremic Toxin Concentration.
Vanholder RC; Eloot S; Glorieux GL
Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
[TBL] [Abstract][Full Text] [Related]
36. Uremic solutes modulate hepatic bile acid handling and induce mitochondrial toxicity.
Weigand KM; Schirris TJJ; Houweling M; van den Heuvel JJMW; Koenderink JB; Dankers ACA; Russel FGM; Greupink R
Toxicol In Vitro; 2019 Apr; 56():52-61. PubMed ID: 30639138
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiological regulation of renal SLC22A organic ion transporters in acute kidney injury: pharmacological and toxicological implications.
Saito H
Pharmacol Ther; 2010 Jan; 125(1):79-91. PubMed ID: 19837111
[TBL] [Abstract][Full Text] [Related]
38. Biochemical and clinical evidence for uremic toxicity.
Bouré T; Vanholder R
Artif Organs; 2004 Mar; 28(3):248-53. PubMed ID: 15046622
[TBL] [Abstract][Full Text] [Related]
39. Renal tubular drug transporters.
Launay-Vacher V; Izzedine H; Karie S; Hulot JS; Baumelou A; Deray G
Nephron Physiol; 2006; 103(3):p97-106. PubMed ID: 16554667
[TBL] [Abstract][Full Text] [Related]
40. [Uremic toxins: the case of protein-bound compounds].
Basile C; Libutti P; Teutonico A; Lomonte C
G Ital Nefrol; 2010; 27(5):498-507. PubMed ID: 20922681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]